# China Organ Preservation Market > China Organ Preservation Market Research Report: Size, Share, Trend Analysis By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage),By Organ Type (Kidney, Liver, Heart, Lungs) and By End Users (Hospitals & Clinics, Organ Banks) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.08% - **2024:** $ 25.5 Million - **2025:** $ 27.56 Million - **2035:** $ 59.93 Million - **Key Players:** Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Paragonix Technologies (US), Bridge to Life (US), Preservation Solutions (US) **Report ID:** MRFR/HC/47706-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/china-organ-preservation-market-49457 --- ## Market Summary ## **China Organ Preservation Market Overview** As per MRFR analysis, the China Organ Preservation Market Size was estimated at 19.28 (USD Million) in 2023. The China Organ Preservation Market Industry is expected to grow from 20.4(USD Million) in 2024 to 37.2 (USD Million) by 2035. The China Organ Preservation Market CAGR (growth rate) is expected to be around 5.613% during the forecast period (2025 - 2035). ## **Key China Organ Preservation Market Trends Highlighted** The China Organ Preservation Market is experiencing several key market trends driven by advancements in technology and an increasing demand for organ transplants. The government of China has been promoting organ donation and transplantation as part of its healthcare reforms. Recent initiatives to improve organ preservation techniques have led to a higher survival rate for organs during transplants. This has resulted in increased interest from healthcare facilities to adopt better preservation solutions. Organizations in China are focusing on developing new preservation methodologies, which include hypothermic machine perfusion and the use of novel preservation solutions aimed at extending organ viability. Opportunities in the China Organ Preservation Market are abundant due to the growing need for effective organ storage solutions. There is a notable rise in the aging population in China, leading to more instances of organ failure and the subsequent demand for transplants. As healthcare infrastructure continues to improve, especially in rural areas, there is potential for expanding organ preservation technologies to a wider demographic. Additionally, collaborations between academic institutions and medical technology companies present opportunities for innovation in preservation methods. Trends in recent times reflect a shift towards personalized medicine and precision organ transplantation. With advancements in biopreservation technologies, the focus has been on developing tailored solutions that can cater to specific organ types and donor conditions. Furthermore, the emphasis on training healthcare professionals in organ preservation techniques is growing. This is essential for ensuring that advancements lead to practical applications in hospitals and transplant centers across China, ultimately improving patient outcomes in organ transplantation. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **China Organ Preservation Market Drivers** ### **Increasing Organ Transplants Demand in China** One major factor propelling the China [Organ Preservation Market](../../../reports/organ-preservation-market-6073) Industry is the rise in organ transplant procedures in China. According to China's National Health Commission, there are more than 300,000 people on the waiting list for organ transplants, which is driving up demand for preserved organs. Organizations like the Red Cross Society of China, which promotes organ donation programs, have been instrumental in the recent shift in public understanding. As a result, organ donation rates have grown, and there is a greater need for preservation methods to keep these organs viable while being transported. Furthermore, the need for sophisticated organ preservation techniques is highlighted by a noticeable rise in the number of kidney and liver transplants, which are among the most common operations. About 10,000 kidney transplants were carried out in 2019, and as awareness rises and preservation methods advance, this number is expected to rise. The need for effective organ preservation solutions is being further fueled by the growing medical infrastructure. ### **Technological Advancements in Organ Preservation Techniques** Continuous Research and Development (R&D) efforts in organ preservation technologies are shaping the future of the China Organ Preservation Market Industry. Notable advancements in preservation techniques, such as machine perfusion and novel cryopreservation methods, have increased organ viability outside the body. Organizations like the Chinese Academy of Medical Sciences are pioneering innovations, with research demonstrating that machine perfusion can extend preservation time by up to 50%. This technological evolution is critical in addressing the growing number of transplant surgeries and managing the limited organ supply effectively. By supporting improved transportation and longer storage times, these advancements are vital in bridging the gap between organ donation and transplantation needs. ### **Government Initiatives Supporting Organ Donation** Government policies and initiatives promoting organ donation in China are fundamental drivers for the China Organ Preservation Market Industry. The Chinese government has implemented several regulations encouraging organ donation, such as the establishment of a national organ donation system in 2010. This system has seen a steady increase in donations, ascending from 4,000 in 2011 to nearly 38,000 in 2020. These initiatives not only enhance public awareness but also create an ecosystem where organ preservation becomes essential to support the growing number of donations. Furthermore, factors like the recent spike in health concerns due to COVID-19 prompting a broader societal discussion on health and organ health awareness, it emphasizes the importance of efficient organ preservation strategies. ## **China Organ Preservation Market Segment Insights** ### **Organ Preservation Market Solution Insights** The China Organ Preservation Market related to Solutions holds a significant position in ensuring the viability of organs for transplantation. This segment encompasses various solutions tailored to meet the needs of preservation at different temperatures and durations, ensuring optimal conditions to maintain organ functionality. University of Wisconsin Solution is widely recognized for its ability to prolong organ preservation times. Custodial HTK Solution offers a balanced formulation advantageous for liver and kidney preservation. Collins Solution is primarily used for cardiac preservation and has been pivotal in advancing cardiac transplantation success rates. Further, the Celsior Solution is now gaining traction among physicians due to its favorable outcomes in heart and liver transplantation, reflecting the continuous evolution in preservation technology. Perfadex is particularly highlighted for its effectiveness in preserving lungs, which are delicate and require precise handling to prevent damage during transport. Citrate Solution, often utilized in kidney preservation, adds another layer of efficiency, ensuring that the organs remain in a stable condition before transplantation. The growth of the China Organ Preservation Market is influenced by factors such as increasing organ donation rates, advancements in medical technology, and a growing healthcare network. The importance of these solutions lies not only in their diverse applications but also in their ability to adapt to the specific requirements of each organ type, signifying their pivotal role in the broader context of organ transplantation and preservation. Additionally, the rising number of transplant procedures in China continues to drive demand for effective preservation solutions, thereby nurturing market growth. As the nation's healthcare infrastructure develops and awareness of organ donation increases, the demand for reliable solutions is expected to rise, enhancing overall patient outcomes and saving lives. This growth trajectory underlines the crucial role the Solutions segment plays in the overall dynamics of the China Organ Preservation Market. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Organ Preservation Market Preservation Techniques Insights** The Preservation Techniques segment of the China Organ Preservation Market plays a critical role in ensuring the viability of organs for transplantation. This segment encompasses various methods, primarily Static Cold Storage and Dynamic Cold Storage, which contribute significantly to the overall efficiency of organ preservation. Static Cold Storage remains a widely utilized technique due to its simplicity and effectiveness in maintaining organ viability in a controlled environment. Dynamic Cold Storage is increasingly gaining traction because it allows for more advanced preservation through continuous oxygenation and temperature control. Dynamic Cold Storage enhances the organ's metabolic state during transportation. As the China Organ Preservation Market responds to growing transplantation demands driven by an aging population and rising incidences of organ failures, these preservation techniques are pivotal in improving donor organ availability and reducing waste. Moreover, advancements in technology and increased investments in Research and Development within the healthcare sector are expected to propel the growth of this segment. The China government’s focus on enhancing healthcare infrastructure further supports the potential growth and innovation in this vital area, capturing a significant share of the organ preservation landscape in the country. Overall, the Preservation Techniques segment remains integral to ensuring successful transplant outcomes, thereby addressing the critical needs of patients in China. ### **Organ Preservation Market Organ Type Insights** The China Organ Preservation Market is experiencing significant growth, driven by advancements in medical technology and rising awareness around organ donation and preservation methods. The Organ Type segment encompasses critical categories such as Kidney, Liver, Heart, and Lungs, each playing a vital role in transplantation and medical treatments. The Kidney segment holds a major share due to the high demand for kidney transplants. The Liver segment is also crucial as liver diseases are prevalent. The Heart segment is important as cardiovascular diseases are a leading cause of mortality. The Lungs segment is vital given the increasing incidence of respiratory diseases. Overall, the growing number of patients on transplant lists and the need for efficient preservation methods highlight the importance of these organ types in the China Organ Preservation Market. This reflects a broader trend toward improved healthcare practices and technologies across the nation. ### **Organ Preservation Market End User Insights** The End User segment of the China Organ Preservation Market plays a critical role in the overall landscape of the industry, comprising various key players that facilitate organ preservation processes. Hospitals and Clinics represent a major portion of this segment, functioning as primary centers where organ transplantation procedures occur. These institutions are equipped with advanced technologies for organ preservation. Organ Banks also significantly contribute to this market, acting as centralized repositories that manage and store donated organs before transplantation. The importance of these banks is underscored by their systematic approach to matching donors with recipients, which is crucial for improving transplant success rates. Furthermore, trends in the China Organ Preservation Market indicate a growing collaboration between hospitals, clinics, and organ banks, emphasizing the importance of integrated healthcare solutions. Challenges such as the need for standardized preservation protocols and efficient logistics persist, yet they also present opportunities for innovation in preservation techniques and technology within these facilities. Overall, the End User segment is essential for ensuring that the benefits of organ preservation translate into successful transplantation outcomes in China. ## **China Organ Preservation Market Key Players and Competitive Insights** The China Organ Preservation Market is an evolving sector that has gained remarkable attention due to increasing organ transplant procedures and a growing demand for effective organ preservation techniques. In this competitive landscape, various companies are vying for market share by innovating preservation solutions and expanding their distribution networks. Advancements in technology, a focus on improving transplant outcomes, and increased healthcare investments have spurred growth in this market. Moreover, the regulatory environment in China, emphasizing the importance of organ donation and transplantation, adds another layer of complexity to the competition. Companies are pushing for better performance and efficiency in organ preservation solutions, leading to enhanced partnerships, research collaborations, and strategic expansions to solidify their market position. ### **Sinopharm** Sinopharm has established a prominent presence in the China Organ Preservation Market by capitalizing on its extensive distribution network and strong government relationships. The company's strengths lie in its ability to integrate logistics and supply chain management to ensure efficient delivery of organ preservation products. As one of the leading pharmaceutical firms in China, Sinopharm benefits from economies of scale, allowing it to offer competitive pricing and reliable services. Additionally, its commitment to research and development enables the company to stay ahead in innovation, particularly in the areas of low-temperature preservation and preservation solutions that extend organ viability. With a reputation for reliability in the healthcare sector, Sinopharm has gained substantial trust and confidence from transplant centers and hospitals. ### **United Therapeutics Corporation** United Therapeutics Corporation operates with a specialized focus within the China Organ Preservation Market, particularly known for its innovative contributions to organ transplant technologies and preservation methods. The company has made significant inroads in the region through its advanced products and technologies aimed at improving organ viability and transplant outcomes. United Therapeutics Corporation boasts a strong portfolio that includes key offerings tailored for organ preservation, leveraging novel techniques to enhance preservation times. The company has strategically positioned itself by securing collaborations and partnerships with local healthcare providers and research institutions. Recent mergers and acquisitions further demonstrate its intent to enhance its market presence, effectively expanding its capabilities and access to cutting-edge preservation technology. United Therapeutics Corporation's focus on research translates into ongoing improvements in product offerings, reinforcing its commitment to revolutionizing organ preservation in China. ### **Key Companies in the China Organ Preservation Market Include** ## **China Organ Preservation Market Industry Developments** Recent developments in the China Organ Preservation Market highlight significant advancements and collaborations among key players. In June 2023, United Therapeutics Corporation announced a strategic partnership with Beijing Shijitan Hospital to enhance organ preservation processes, aiming to improve organ viability for transplantation. Research initiatives have ramped up at Xi'an Jiaotong University as they unveiled a new cryopreservation technology that holds promise for better organ recovery rates. Additionally, Wuxi Apptec has expanded its capabilities to provide enhanced logistic solutions for organ transportation, integrating innovative preservation techniques to better serve hospitals nationwide. Jiangsu University and Zhejiang University continue to contribute through collaborative Research and Development efforts focusing on long-term organ storage methodologies. Notably, there have been discussions surrounding mergers; however, as of October 2023, no substantial acquisition activity has been publicly disclosed within the specific companies of interest. Overall, the market is witnessing a surge in technological advancements and academic collaborations, strengthening the foundation for future growth in organ preservation techniques across China. ## **China Organ Preservation Market Segmentation Insights** ### **Organ Preservation Market Solution Outlook** ### **Organ Preservation Market Preservation Techniques Outlook** ### **Organ Preservation Market Organ Type Outlook** ### **Organ Preservation Market End User Outlook** ## Market Drivers ### Increasing Demand for Transplants The rising incidence of organ failure in China is driving the demand for organ transplants, thereby propelling the organ preservation market. According to recent statistics, the number of patients requiring organ transplants has surged, with estimates suggesting a growth rate of approximately 10% annually. This increasing demand necessitates effective organ preservation techniques to ensure the viability of harvested organs. The organ preservation market is thus witnessing innovations aimed at enhancing preservation methods, which are crucial for successful transplant outcomes. As the population ages and lifestyle-related diseases become more prevalent, the urgency for effective organ preservation solutions is likely to intensify, further stimulating market growth. ### Government Initiatives and Funding The Chinese government is actively promoting organ donation and transplantation, which is positively impacting the organ preservation market. Initiatives aimed at increasing public awareness and improving the regulatory framework for organ donation are being implemented. Furthermore, government funding for research and development in organ preservation technologies is on the rise. This support is crucial for fostering innovation within the organ preservation market. With the government’s commitment to enhancing transplant success rates, the market is likely to see increased investment in advanced preservation techniques, which could lead to a more robust and efficient organ transplantation system in China. ### Growing Awareness of Organ Donation Public awareness regarding the importance of organ donation is gradually increasing in China, which is beneficial for the organ preservation market. Campaigns aimed at educating the population about the need for organ donors are gaining traction, leading to a rise in registered donors. This growing awareness is essential for ensuring a steady supply of organs for transplantation, thereby driving the demand for effective preservation methods. The organ preservation market is likely to see a corresponding increase in the development of preservation solutions that cater to the needs of a larger donor pool. As societal attitudes shift towards organ donation, the market may experience a significant boost in growth opportunities. ### Advancements in Preservation Technologies Technological innovations in organ preservation methods are significantly influencing the organ preservation market. Recent developments in hypothermic and normothermic preservation techniques have shown promise in extending the viability of organs outside the human body. For instance, the introduction of machine perfusion systems has been associated with improved outcomes in organ transplantation. The organ preservation market is expected to benefit from these advancements, as they not only enhance organ viability but also reduce the risk of transplant rejection. As hospitals and transplant centers in China increasingly adopt these technologies, the market is likely to experience substantial growth, with projections indicating a potential increase in market size by 15% over the next five years. ### Collaboration Between Healthcare Institutions Collaborative efforts among healthcare institutions, research organizations, and biotechnology firms are shaping the organ preservation market. These partnerships are focused on developing innovative preservation techniques and improving existing methods. By pooling resources and expertise, stakeholders are likely to accelerate advancements in the organ preservation market. Such collaborations can lead to the establishment of best practices and standardized protocols, which are essential for enhancing the efficiency of organ preservation. As more institutions in China engage in these collaborative initiatives, the market is expected to expand, with a potential increase in the adoption of cutting-edge preservation technologies. ## Future Outlook The [Organ Preservation Market](https://www.marketresearchfuture.com/reports/organ-preservation-market-6073) in China is projected to grow at 8.08% CAGR from 2025 to 2035, driven by technological advancements and increasing organ transplant demand. **New opportunities:** - Development of advanced preservation solutions with extended shelf life. Implementation of AI-driven logistics for organ transport efficiency. Partnerships with hospitals for integrated organ preservation services. By 2035, the organ preservation market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Solution: Citrate Solution (Largest) vs. University of Wisconsin Solution (Fastest-Growing) In the China organ preservation market, the distribution of market share among the various solutions reflects a diverse and competitive landscape. Citrate Solution currently represents the largest segment, appealing to a wide range of healthcare providers due to its effectiveness and reliability in preserving organs. Meanwhile, the University of Wisconsin Solution is gaining traction, highlighted by its superior performance and growing adoption rates among transplant surgeons, making it a formidable contender in this segment. Growth trends indicate a robust increase in demand for organ preservation solutions, driven by advancements in transplant technologies and increasing organ transplant procedures. The rise in awareness regarding the benefits of effective organ preservation is fueling the market further. Additionally, government support for organ transplant initiatives and innovations in preservation techniques are contributing significantly to the rapid adoption of emerging solutions like the University of Wisconsin Solution, positioning it as a key player in this dynamic market. Citrate Solution (Dominant) vs. University of Wisconsin Solution (Emerging) Citrate Solution has established itself as a dominant force in the organ preservation segment, prized for its ability to enhance organ viability and function during transportation. Its formulation is specifically designed to reduce cellular metabolism, offering a protective effect that prolongs the lifespan of organs outside the body. In contrast, the University of Wisconsin Solution, though emerging, has quickly gained favor among medical professionals for its unique composition that optimally preserves kidney function, especially in deceased donor transplants. This solution is known for its effectiveness in minimizing ischemic damage, making it central to discussions about future advancements in preservation methods. As transplant rates increase, both solutions will play critical roles, albeit with Citrate Solution leading the current market share. ### By Preservation Techniques: Static Cold Storage (Largest) vs. Dynamic Cold Storage (Fastest-Growing) In the China organ preservation market, Static Cold Storage holds the largest market share due to its established use and reliability in preserving organs for transplantation. This method has become the foundational technique in many hospitals and organ transplant centers, demonstrating its efficacy and broad acceptance. On the other hand, Dynamic Cold Storage is gaining traction, appealing to institutions looking for advanced preservation solutions that ensure better outcomes for organ viability. Preservation Techniques: Static Cold Storage (Dominant) vs. Dynamic Cold Storage (Emerging) Static Cold Storage is characterized by its ability to maintain organs at low temperatures using a consistent low-temperature environment, which has been traditionally effective in preventing organ deterioration. Its long-standing presence in the China organ preservation market has instilled confidence among medical professionals. Conversely, Dynamic Cold Storage represents a forward-looking approach, utilizing controlled perfusion techniques to optimize organ preservation. This emerging technology is seen as vital for enhancing organ viability, and its adoption is rapidly growing as healthcare facilities seek to improve transplant success rates and respond to increasing organ demand. ### By Organ Type: Kidney (Largest) vs. Liver (Fastest-Growing) The organ preservation market is distinctly segmented with the Kidney leading in market share, indicating a strong demand from transplant centers and hospitals prioritizing renal transplants. This dominance in the segment reflects the high incidence of kidney-related diseases and the growing number of patients requiring renal replacement therapies. On the other hand, the Liver segment shows considerable growth, reflecting advancements in preservation techniques and increasing awareness among healthcare providers about the importance of effective liver transplant programs. Growth trends within the organ preservation segment are influenced by several factors, including advancements in preservation technology, increased investment in research, and rising incidences of organ failure. The Liver segment is experiencing robust growth due to innovations in storage solutions and a rise in liver transplant procedures. Additionally, regulatory approvals for new preservation techniques are driving both segments, as healthcare providers seek to enhance organ viability and improve patient outcomes. Kidney (Dominant) vs. Lungs (Emerging) The Kidney segment is characterized by its established market position, driven by a high volume of transplants and supportive healthcare infrastructure dedicated to renal care. It is often viewed as the backbone of organ preservation efforts due to its significant role in alleviating chronic kidney disease. In contrast, the Lungs segment represents an emerging opportunity within the market, as it is less developed but showing promise due to increased focus on treating pulmonary conditions. Advances in lung preservation technology, alongside increasing recognition of the need for lung transplants, mark a shift towards a more structured approach to lung preservation in clinical settings. ### By End-User: Hospitals & Clinics (Largest) vs. Organ Banks (Fastest-Growing) In the China organ preservation market, the end-user segment is primarily divided between hospitals & clinics and organ banks. Hospitals and clinics hold the largest share, driven by their critical role in organ transplantation and the urgent need for effective preservation solutions. Organ banks, while smaller in terms of market share, are experiencing significant growth due to increasing awareness and advancements in preservation technologies. The growth trends within the end-user segment are influenced by several factors, including rising organ transplantation rates and the expansion of organ donation programs. Hospitals and clinics are continually seeking innovative solutions for preservation to enhance organ viability and improve patient outcomes. Meanwhile, organ banks are rapidly evolving, with a focus on developing more efficient preservation methods that cater to the needs of healthcare providers and patients alike, contributing to their status as the fastest-growing segment. Hospitals & Clinics (Dominant) vs. Organ Banks (Emerging) Hospitals and clinics, being the dominant end-users in the China organ preservation market, are equipped with advanced medical technology and protocols for organ handling. These entities prioritize reliable preservation solutions to ensure optimal organ viability for transplant procedures. They often partner with specialists to enhance preservation techniques and thus improve overall transplant success rates. On the other hand, organ banks represent an emerging segment, showing promising growth as they focus on innovation in preservation methods. They play a vital role in the supply chain by ensuring the availability of preserved organs for transplantation. Organ banks are increasing their collaboration with hospitals and research institutions to develop new technologies that enhance preservation efficacy, thus gaining a stronger foothold in the market. ## Competitive Benchmarking The organ preservation market is currently characterized by a dynamic competitive landscape, driven by advancements in technology and increasing demand for organ transplants. Key players are focusing on innovation and strategic partnerships to enhance their operational capabilities. For instance, Organ Recovery Systems (US) has positioned itself as a leader in the development of preservation solutions that extend organ viability, while TransMedics (US) emphasizes its cutting-edge organ perfusion technology, which is pivotal in improving transplant outcomes. Similarly, Xvivo Perfusion (SE) is known for its innovative approaches to organ preservation, particularly in the realm of lung and heart transplants, indicating a trend towards specialization among competitors. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological advancement and operational efficiency.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure of the organ preservation market appears moderately fragmented, with several key players exerting influence over their respective niches. This fragmentation allows for a variety of approaches to organ preservation, fostering innovation while also creating challenges in terms of market share and customer loyalty. In October Paragonix Technologies (US) announced a strategic partnership with a leading transplant center to enhance the adoption of its organ preservation devices. This collaboration is expected to facilitate clinical trials and expand the reach of Paragonix's innovative solutions, thereby solidifying its market position. The strategic importance of this partnership lies in its potential to accelerate the integration of advanced preservation technologies into clinical practice, ultimately improving patient outcomes. In September Bridge to Life (US) launched a new preservation solution aimed at increasing the viability of organs during transport. This product introduction is significant as it addresses a critical challenge in organ transplantation, namely the time-sensitive nature of organ viability. By enhancing the preservation process, Bridge to Life is likely to strengthen its competitive edge and appeal to transplant centers seeking reliable solutions. In August Tissue Regenix (GB) expanded its operations into the Asian market, focusing on the growing demand for organ preservation technologies in that region. This strategic move is indicative of a broader trend towards geographical expansion among key players, as companies seek to tap into emerging markets with increasing healthcare needs. The implications of this expansion could be profound, as it may lead to increased competition and innovation in the organ preservation sector. As of November current trends in the organ preservation market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) into preservation technologies. Strategic alliances are becoming increasingly important, as companies recognize the value of collaboration in enhancing their technological capabilities. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability. This shift suggests that companies that prioritize research and development, alongside strategic partnerships, will be better positioned to thrive in an increasingly competitive landscape. ## Recent News & Developments Recent developments in the China Organ Preservation Market highlight significant advancements and collaborations among key players. In June 2023, United Therapeutics Corporation announced a strategic partnership with Beijing Shijitan Hospital to enhance organ preservation processes, aiming to improve organ viability for transplantation. Research initiatives have ramped up at Xi'an Jiaotong University as they unveiled a new cryopreservation technology that holds promise for better organ recovery rates. Additionally, Wuxi Apptec has expanded its capabilities to provide enhanced logistic solutions for organ transportation, integrating innovative preservation techniques to better serve hospitals nationwide. Jiangsu University and Zhejiang University continue to contribute through collaborative Research and Development efforts focusing on long-term organ storage methodologies. Notably, there have been discussions surrounding mergers; however, as of October 2023, no substantial acquisition activity has been publicly disclosed within the specific companies of interest. Overall, the market is witnessing a surge in technological advancements and academic collaborations, strengthening the foundation for future growth in organ preservation techniques across China. ## Report Scope | MARKET SIZE 2024 | 25.5(USD Million) | | --- | --- | | MARKET SIZE 2025 | 27.56(USD Million) | | MARKET SIZE 2035 | 59.93(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.08% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Paragonix Technologies (US), Bridge to Life (US), Preservation Solutions (US) | | Segments Covered | Solution, Preservation Techniques, Organ Type, End-User | | Key Market Opportunities | Advancements in preservation techniques enhance organ viability, driving demand in the organ preservation market. | | Key Market Dynamics | Technological advancements in organ preservation techniques drive competitive dynamics and regulatory adaptations in the market. | | Countries Covered | China | ## Frequently Asked Questions **Q: What is the current valuation of the organ preservation market in China as of 2024?** A: The organ preservation market in China was valued at $25.5 Million in 2024. **Q: What is the projected market valuation for the organ preservation market in China by 2035?** A: The market is projected to reach $59.93 Million by 2035. **Q: What is the expected CAGR for the organ preservation market in China during the forecast period 2025 - 2035?** A: The expected CAGR for the market during 2025 - 2035 is 8.08%. **Q: Which organ types are leading in market valuation within the organ preservation sector in China?** A: The leading organ types include Liver at $7.6 Million, Kidney at $5.1 Million, Heart at $6.4 Million, and Lungs at $6.4 Million. **Q: What are the key preservation techniques utilized in the organ preservation market in China?** A: Key preservation techniques include Static Cold Storage valued at $10.5 Million and Dynamic Cold Storage at $15.0 Million. **Q: Which solutions are most commonly used in the organ preservation market in China?** A: Common solutions include University of Wisconsin Solution at $5.1 Million, Custodial HTK at $4.5 Million, and Collins Solution at $3.8 Million. **Q: Who are the major players in the organ preservation market in China?** A: Major players include Organ Recovery Systems, TransMedics, Xvivo Perfusion, and LifeLink Foundation. **Q: What is the market valuation for hospitals and clinics as end-users in the organ preservation market in China?** A: The market valuation for hospitals and clinics as end-users was $15.3 Million. **Q: How does the market valuation for organ banks compare to hospitals and clinics in China?** A: The market valuation for organ banks was $10.2 Million, which is lower than that of hospitals and clinics. **Q: What trends are expected to shape the organ preservation market in China by 2035?** A: Trends may include advancements in preservation technologies and increased demand for organ transplants, driving market growth. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-organ-preservation-market-49457*